Portnoy
Emma Portnoy, Beer-Sheva IL
Patent application number | Description | Published |
---|---|---|
20130209368 | NEAR INFRARED FLUORESCENT PARTICLES AND USES THEREOF - The present invention provides particles comprising either a water-soluble polymer or a phospholipid, wherein at least one near infrared (NIR) fluorescent probe and optionally at least one active agent such as a targeting moiety, capable of selectively recognizing a particular cellular marker, are non-covalently bound to the outer surface of the particles. Pharmaceutical compositions comprising these particles may be used, inter alia, for detection and treatment of tumors in the gastrointestinal tract | 08-15-2013 |
Emma Portnoy, Jerusalem IL
Patent application number | Description | Published |
---|---|---|
20150119698 | Compositions Comprising Near-Infrared Fluorescent Particles And Uses Thereof For Imaging Activated Immune Cells In the CNS - Pharmaceutical composition including nanoparticles configured for enhanced phagocytosis by phagocytic cells and labeled with a near-infrared (NIR) fluorescent probe bound to the outer surface thereof, and uses thereof in the detection of activated immune cells in the central nervous system (CNS) of a subject. | 04-30-2015 |
Irina Portnoy, Nesher IL
Patent application number | Description | Published |
---|---|---|
20110038987 | BETA-CASEIN ASSEMBLIES FOR ENRICHMENT OF FOOD AND BEVERAGES AND METHODS OF PREPARATION THEREOF - The invention relates to a composition for the enrichment of food and/or beverage and to a method of preparing such composition. The composition comprises additive loaded beta-casein micelles which are of a diameter of about 100 nm or less. These nano-sized beta-casein assemblies are formed at pH values which are preferably one or more pH units above or below the pI of the protein (pI=5.3). More preferably the beta-casein nano-assemblies are formed at a pH range between about 6.0 and about 8, or between about 2.0 and about 4.2. The invention provides vehicles for delivery of additives via transparent beverages and other foods and drinks and/or acidic foods and drinks and/or non fat foods and drinks. | 02-17-2011 |
Moshe Portnoy, Ramat-Hasharon IL
Patent application number | Description | Published |
---|---|---|
20100093704 | NOVEL PSYCHOTROPIC AGENTS HAVING GLUTAMATE NMDA ACTIVITY - The invention provides novel compounds and pharmaceutical compositions for the treatment of psychological and/or psychiatric diseases or disorders. | 04-15-2010 |
20100130549 | PSYCHOTROPIC COMPOUNDS, COMPOSITIONS AND METHODS OF USE - The present invention provides a method for treating or preventing a disease or disorder treatable by the inhibition of serotonin reuptake in a patient, and/or norepinephrine reuptake and/or dopamine reuptake in a patient, the method comprising administering to the patient a neurotransmitter reuptake inhibiting-effective amount of at least one compound of the formula A-L-B (I) or a pharmaceutically acceptable salt, ester or prodrug thereof, wherein A is a psychotropic derivative; L is a linking group comprising two carbon atoms; and B is an alkyl, alkenyl, alkynyl or aralkyl comprising at least one substituent of the formula Q, wherein: the alkyl, alkenyl, alkynyl or aralkyl is optionally substituted with one or more halogean halogens, hydroxyl, cyano, nitro, amino or thiol; and Q is OR | 05-27-2010 |
20130131048 | NOVEL PSYCHOTROPIC AGENTS HAVING GLUTAMATE NMDA ACTIVITY - The invention provides novel compounds and pharmaceutical compositions for the treatment of psychological and/or psychiatric diseases or disorders. | 05-23-2013 |
Moshe Portnoy, Givat Shmuel IL
Patent application number | Description | Published |
---|---|---|
20080312188 | Glycogen synthase kinase-3 inhibitors - Novel compounds designed to allow interactions with binding sites of GSK-3 and hence are capable of inhibiting GSK-3 activity, via inhibition of substrate binding are disclosed. Further disclosed are pharmaceutical compositions including same and methods of using same in the treatment of GSK-3 mediated conditions. | 12-18-2008 |
20100279990 | ANTIPROLIFERATIVE COMPOUNDS, COMPOSITIONS AND METHODS OF USE - The present invention provides a compound of the formula A-L-B (I) or a pharmaceutically acceptable salt, ester or prodrug thereof, wherein A is a psychotropic derivative; L is a linking group comprising two carbon atoms; and B is an alkyl, alkenyl, alkynyl or aralkyl comprising at least one substituent of the formula Q, wherein: the alkyl, alkenyl, alkynyl or aralkyl is optionally substituted with one or more halogens, hydroxyl, cyano, nitro, amino or thiol; and Q is OR | 11-04-2010 |
Roger Portnoy, London GB
Patent application number | Description | Published |
---|---|---|
20090265279 | SYSTEM AND METHOD FOR MANAGING AND DISTRIBUTING HEDGE FUND DATA - A system for managing hedge funds includes a storage unit operable to store hedge fund information. The hedge fund information comprises at least one of a fund name, a fund share class, and denominated currency of a fund share class for a hedge fund. The system further includes a determination unit operable to determine, upon receiving hedge fund information, if the hedge fund information corresponds to a known hedge fund based on the received hedge fund information. The determination unit is operable to compare hedge fund information from a plurality of information sources so as to confirm whether the received hedge fund information relates to the same hedge fund. | 10-22-2009 |
Tali Portnoy, Binyamina IL
Patent application number | Description | Published |
---|---|---|
20140210971 | Navigation Using a Pre-Acquired Image - A method for imaging, including capturing an initial image of a surface under investigation using a first endoscope, and delineating within the initial image a target region of interest surrounded by an initial image peripheral region, the target region of interest having a location defined with respect to the initial image peripheral region. The method includes capturing a subsequent image of the surface under investigation using a second endoscope and identifying in the subsequent image, by comparison with characteristics of the initial image peripheral region, a subsequent image peripheral region corresponding to the initial image peripheral region. The further includes computing the location of the target region of interest in the subsequent image in response to the identified subsequent image peripheral region. | 07-31-2014 |
Vitaly Portnoy, Nesher IL
Patent application number | Description | Published |
---|---|---|
20120324597 | MELON PLANTS COMPRISING TETRA-CIS-LYCOPENE | 12-20-2012 |